Home / News


Single-cell analysis using supercomputers

New CEO commentary: “The Single-Cell Revolution”

PHI’s CEO and founder Peter Egelberg comments the recently published innovation report from the UN agency World Intellectual Property Organization.
Learn more

Kommuniké från årsstämma i Phase Holographic Imaging AB (publ)

Phase Holographic Imaging AB (publ) avhöll den 15 oktober 2019 sin årsstämma.
Learn more

Förslag till styrelse för Phase Holographic Imaging PHI AB

Inför årsstämman i Phase Holographic Imaging AB den 15 oktober föreslås omval av Maria Morin, Linda Neckmar, Johan Hyllner, Leland Foster, Mats Lundwall samt Jan Richardsson som ordinarie styrelseledamöter.
Learn more

New SelectScience eBook helps scientists choose the best cell imaging technology

A new cell imaging technology guide has been launched by leading independent science publisher SelectScience® to help scientists find the best equipment for their applications.
Learn more

Interim Report 1 2019/20

Interim Report 1 (2019-05-01 – 2019-07-31) from Phase Holographic Imaging.
Learn more

Årsredovisning 2018/19

Styrelsen och verkställande direktören för Phase Holographic Imaging PHI AB (publ), organisationsnummer 556542-7811 och med säte i Lund, avger härmed årsredovisning för räkenskapsåret 1 maj 2018 – 30 april 2019.  
Learn more

Kallelse till årsstämma i Phase Holographic Imaging PHI AB (publ)

Aktieägarna i Phase Holographic Imaging PHI AB (publ), 556542-7811, kallas härmed till årsstämma tisdagen den 15 oktober 2019 kl. 17.00 i bolagets lokaler, Scheelevägen 22 i Lund. Rätt att delta och anmälan Aktieägare som önskar delta i bolagsstämman ska vara införd i den av Euroclear Sweden AB förda aktieboken onsdagen den 9 oktober 2019, och …
Learn more
PHI building

US National Institutes of Health intends to purchase HoloMonitor

The US National Institute of Aging intends to purchase a HoloMonitor instrument from Phase Holographic Imaging. The National Institute of Aging is part of the National Institutes of Health (NIH), a government agency to promote medical research.
Learn more

Minor insider divestment

PHI Board member Jan Richardsson recently divested 5 328 shares in the company. “The reason for the sale is that I needed to balance an option loss linked to a previous employment”, comments Richardsson.
Learn more

Correction regarding the publication date of coming interim report

Previously communicated publication date for Interim Report 1 2019/20 was incorrect. The correct publication date is September 23, 2019 and nothing else.
Learn more